The relations between contraceptive use and GDM: A comparative study

Main Article Content

Atiya Kareem Mohammed
Mahabat Hassan Saeed
Soran Hussein Mohammed


Contraceptive, gestational diabetes mellitus, comparative study


Background: Contraceptive effectiveness and safety have been questioned for decades. However, it is uncertain if hormonal contraceptives and (GDM) are linked.
Aims of the study: The study aimed to find out the relationships between the types of contraceptives used before pregnancy and GDM attended Sulaimani City Gestational Diabetes Mellitus Center.
Design of the study: This is a prospective comparative study.
Material and Methods: Direct interviews with study participants were used to obtain data. After gaining agreement, the researcher administered questionnaires to 602 pregnant women. This study enrolled 602 pregnant women, 300 pregnant women were enrolled in GDM groups and 302 for no -GDM, with a gestational age of 24–28weeks and a maternal age of 18 years or more who used hormonal contraception, including the tablet, intrauterine devices (IUD), contraceptive patches, cervical rings, and injections (administered monthly or every 3 months). Pregnant women below 18 years, with a history of taking drugs that affect glucose metabolisms such as corticosteroids, progesterone, and beta-agonists, and not using contraceptive methods were excluded from our study. The data were obtained via convenience sampling and a specialized questionnaire separated into three sections, including demographic techniques, obstetrics, and family planning from February 1, 2022, to May 15, 2022. The data was analyzed using SPSS version 21. The P-value and Chi-Square tests were performed to see if the variables have a significant association. Significant values are those that are less than 0.05.

Results: According to the findings, 78.5 % of GDM respondents and 66.0 % of non-GDM respondents used hormonal contraception. This study discovered that there was a significant variation between the two groups with age, instruction levels, BMI, equality, contraceptive type, and term of contraception since the p-value was less than 0.0 5. Nevertheless, there were no changes to either residency or employment.
Conclusion: The findings imply a link between GDM and the contraceptive technique used. To affirm contraception as a conceivable chance calculation for GDM, more consideration is needed. 

Abstract 148 | pdf Downloads 154


1. Afolabi SO, Folahan J, Agede O, et al. Combined intranasal insulin/saxagliptin/metformin therapies ameliorate the effect of combined oral
contraceptive- (COC-) induced metabolic syndrome (MetS) with a major target on glucose metabolism in adult female wistar rats. Int J Reprod Med. 2021; 2021: 1–12.
2. Yao W, Dong X, Yu X, et al. The use of oral contraceptive is inversely associated with the risk of type 2 diabetes mellitus among middle-aged
women. Gynecol Endocrinol. 2021; 37(8): 758–763.
3. Gourdy P. Diabetes and oral contraception. Best Pract Res Clin Endocrinol Metab. 2013; 27(1):67–76.
4. Raets L, Beunen K, and Benhalima K. Screening for gestational diabetes mellitus in early pregnancy: what is the evidence? J Clin Med. 2021; 10(6):1257.
5. Sapra A, Bhandari P, and Wilhite A. Diabetes mellitus (nursing). StatPearls Publishing; 2021.
6. Kramer BA, Kintzel J, and Garikapaty V. Association between contraceptive use and gestational diabetes: Missouri pregnancy risk
assessment monitoring system, 2007–2008. Prevent Chron Dis. 2014; 11(4): 1–6.
7. Mohammed AK. Contraceptive practices among breastfeeding mothers. Eur J Med Genet. 2022; 65(6).
8. Li G, Wei T, Ni W, et al. Incidence and risk factors of gestational diabetes mellitus: a prospective cohort study in Qingdao, China. Front
Endocrinol. 2020; 636.
9. Wang YY, Liu Y, Li C, et al. Frequency and risk factors for recurrent gestational diabetes mellitus in primiparous women: a case control study. BMC Endocr Disord. 2019; 19(1): 22.
10. Rönö K, Masalin S, Kautiainen H, et al. The impact of educational attainment on the occurrence of gestational diabetes mellitus in two
successive pregnancies of Finnish primiparous women: a population-based cohort study. Acta Diabetol. 2020; 57(9): 1035–1042.
11. Song L, Shen L, Li H, et al. Socio-economic status and risk of gestational diabetes mellitus among Chinese women. Diabet Med. 2017; 34(10):1421–1427.
12. Bertolotto A, Corfni M, Ghio A, et al. Is maternal educational level a risk factor for gestational diabetes in Caucasian women? Diabet Med. 2012; 29(3): 416–417.
13. Janghorbani M, Stenhouse EA, Jones RB, et al. Is neighbourhood deprivation a risk factor for gestational diabetes mellitus? Diabet Med. 2006; 23(3): 313–317.
14. Carrillo-Larco RM, Bernabé-Ortiz A, Pillay TD, et al. Obesity risk in rural, urban and rural-to-urban migrants: prospective results of the PERU
MIGRANT study. Int J Obes (Lond). 2015; 40:181–185.
15. Vahratian A, Barber JS, Lawrence JM, et al.Family planning practices among women with diabetes and overweight and obese women in the
2002 National Survey For Family Growth. Diabetes Care. 2009; 32(6): 1026–1031.
16. Lawlor DA, Emberson JR, Ebrahim S, et al. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women’s Heart and Health Study and the British Regional Heart St. Circulation. 2003; 107: 1260–1264.
17. McDonald SD, Yusuf S, Sheridan P, et al.Dysglycemia and a history of reproductive risk factors. Diabetes Care. 2008; 31: 1635–1638.
18. Li P, Shan Z, Zhou L, et al. Mechanisms in endocrinology: parity and risk of type 2 diabetes: a systematic review and dose-response metaanalysis. Eur J Endocrinol. 2016; 175(5): R231–R245.
19. Guo P, Zhou Q, Ren L, et al. Higher parity is associated with increased risk of type 2 diabetes mellitus in women: a linear dose– response metaanalysis of cohort studies. J Diabetes Complicat.2017; 31(1): 58–66.
20. Liu B, Jorm L, and Banks E. Parity, breastfeeding, and the subsequent risk of maternal type 2 diabetes. Diabetes Care. 2010; 33: 1239–1241.
21. Kjos SL, Peters RK, Xiang A, et al. Contraception and the risk of type 2 diabetes mellitus in latina women with prior gestational diabetes mellitus. J Am Med Assoc. 1998; 280(6): 533–538.
22. Visser J, Snel M, and Van Vliet HAAM. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Cochrane Database Syst Rev. 2006; 4: CD003990.
23. Diab KM, and Zaki M. Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A. J Obstet Gynaecol Res. 2000; 26(1): 17–26.
24. Burke CW. The effect of oral contraceptives on cortisol metabolism. J Clin Pathol. 1969; S1–3(1):11–18.
25. Andrews RC, and Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci. 1999; 96: 513–523.